Phenomex Inc (CELL) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Phenomex Inc   (NASDAQ: CELL)

Phenomex Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Phenomex Inc in the second quarter 2023?
Phenomex Inc recorded a cumulative net loss of $-125 million during 12 months ending in the second quarter 2023, resulting in a negative return on equity (ROE) of -87.5%.

Within the Laboratory Analytical Instruments industry 25 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2023 from 3065 to 3847.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Equity Change -36.2 % -18.35 % -31.78 % -28.16 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -125 -100 -98 -86 -85
Return On Equity (TTM) -87.5 % -63.27 % -58.72 % -47.12 % -42.87 %
CELL's Total Ranking # 3847 # 3065 # 0 # 0 # 0
Equity (TTM) in Millions 111 158 142 158 174
Seq. Equity Change -29.45 % 11.04 % -10.2 % -9.31 % -9.72 %
Seq. Net Income Change - - - - -

Back to CELL Management Effectiveness >> CELL's 5 Years Annual ROE >> Compare CELL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 26
Sector # 661
Overall # 3847

Return On Equity Statistics
High Average Low
-22.41 %
-42.57 %
-87.5 %
(Jun 30 2021)   (Jun 30 2023)





CELL Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020

Total Equity in Millions 142 208 245 0 0
Y / Y Equity Change -31.78 % -14.94 % - - -
Net Income in Millions -98 -72 -42 0 0
Y / Y Net Income Change - - - - -
Return On Equity -69.02 % -34.45 % -16.99 % - -

Back to CELL Management Effectiveness >> CELL's 5 Years Annual ROE >> Compare CELL ROE to its Competitors




More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CELL's' Return on Equity at Yahoo Finance
CELL's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CELL's Competitors
Subscribers only: Roe for Phenomex Inc 's Suppliers
Subscribers only: Return On Equity for CELL's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.